Related Experiment Video

Updated: Sep 30, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

Integrating surgery and radiotherapy to reduce toxicity while maintaining local control for breast cancer: a fine

Rinaa S Punglia, Jay R Harris

    Annals of Surgical Oncology
    |July 4, 2002
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
    08:54

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

    Published on: May 8, 2018

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Related Experiment Videos

    Last Updated: Sep 30, 2026

    Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
    11:38

    Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

    Published on: July 3, 2014

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
    08:54

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

    Published on: May 8, 2018

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Prospective Comparison of Long-Term Outcomes in Prepectoral vs. Subpectoral Implant Breast Reconstruction After Post-Mastectomy Radiotherapy.

    Plastic and reconstructive surgery·2026

    From Clinical Trial Awareness to Practice: Factors Associated with Intent to Omit Axillary Surgery Based on the SOUND Clinical Trial.

    Annals of surgical oncology·2026

    Geospatial disparities, health system factors, and breast cancer care quality.

    JNCI cancer spectrum·2025

    Decomposing Variations on Cluster Level for Binary Outcomes in Application to Cancer Care Disparity Studies.

    Health services research·2025

    Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States.

    International journal of cancer·2024

    Real-World Implications of the SOUND Trial.

    Annals of surgical oncology·2024

    Prophylactic Pyloric Dilatation and its Impact on Early Delayed Gastric Conduit Emptying and Pneumonia Post-esophagectomy: A Multi-centre Cohort Study.

    Annals of surgical oncology·2026

    Extended Lymphadenectomy is Associated with Better Survival Outcome in Resected T1b-T4 Gallbladder Cancer: A 505-Patient Cohort Study.

    Annals of surgical oncology·2026

    Impact of Systematic Discontinuation of Mitomycin C HIPEC for Colorectal Peritoneal Metastases on Oncologic Outcomes: A Propensity Score-Matched Analysis.

    Annals of surgical oncology·2026

    Outcomes of Elderly Patients with Colorectal Liver Metastases Treated with Liver-Directed Therapies.

    Annals of surgical oncology·2026

    Financial Toxicity in Patients with Resected Esophageal Cancer.

    Annals of surgical oncology·2026

    Radical Antegrade Modular Pancreatosplenectomy Versus Standard Resection in T3 Body and Tail Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Cohort Study.

    Annals of surgical oncology·2026

    Preventing Weight Regain After Glucagon-Like Peptide‑1 Therapy Discontinuation: A Pilot Randomized Controlled Trial.

    Obesity science & practice·2026

    Successful Breast-Conserving Surgery Following Dose-Modified Neoadjuvant Chemoimmunotherapy in an 86-Year-Old Patient With Locally Advanced Triple-Negative Breast Cancer: A Case Report.

    Clinical case reports·2026

    I need it. Without it, I wouldn't have gone, and I do want to go: patient perspectives on the acceptability and appropriateness of two patient-centered interventions to improve adherence to annual lung cancer screening.

    Frontiers in health services·2026

    Immunosuppressive cell populations as potential drivers of extrinsic immune checkpoint inhibition resistance in clear cell renal cell carcinoma.

    Oncology reviews·2026

    Development of a risk-stratified follow-up strategy based on early and late recurrence risk factors in locally advanced esophageal squamous cell carcinoma after definitive chemoradiotherapy.

    Frontiers in oncology·2026

    Multimodality therapy for stage IB3 cervical cancer with a delayed diagnosis at 21 weeks of gestation: from neoadjuvant chemotherapy to adjuvant chemoradiotherapy-a case report.

    Frontiers in medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us